A recent large study conducted in Sweden has found that long-term exposure to elevated levels of air pollution may increase ...
Air pollution was associated with risk for developing motor neuron disease such as ALS and likely contributes to an ...
Pharmaust Ltd.’s monepantel met its primary safety endpoints and showed positive signals of potential efficacy in a phase I trial in patients with motor neuron disease (MND)/amyotrophic lateral ...
Pharmaust Limited (AU:PAA) has released an update. PharmAust Limited has announced the completion of enrolment for their Open-Label Extension study, revealing that their drug monepantel significantly ...
A new study from Sweden found long-term exposure to air pollution is linked to an increased risk of ALS and worse outcomes ...
Could the key to unlocking the secret of motor neurone disease lie in the collaboration between two small island nations, Ireland and Cuba? Researchers from Trinity College Dublin are heading to Latin ...
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that new data were presented at the 32nd International Symposium on ALS/MND ...
STEVENAGE, United Kingdom, Jan. 08, 2026 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial dysfunction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results